4-AMINOPYRIDINE IMPROVES NEUROLOGICAL DEFICITS IN MULTIPLE-SCLEROSIS PATIENTS - DEMONSTRATION IN A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

被引：0
|
作者：
BEVER, CT
YOUNG, D
ANDERSON, P
KRUMHOLZ, A
CONWAY, K
LESLIE, J
EDDINGTON, N
PLAISANCE, K
PANITCH, H
JOHNSON, K
ROSENBERG, L
DEVANE, J
机构：
来源：
NEUROLOGY | 1992年 / 42卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1427 / 1427
页数：1
相关论文
共 50 条
  • [1] THE EFFECTS OF 4-AMINOPYRIDINE IN MULTIPLE-SCLEROSIS PATIENTS - RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, CONCENTRATION-CONTROLLED, CROSSOVER TRIAL
    BEVER, CT
    YOUNG, D
    ANDERSON, PA
    KRUMHOLZ, A
    CONWAY, K
    LESLIE, J
    EDDINGTON, N
    PLAISANCE, KI
    PANITCH, HS
    DHIBJALBUT, S
    FOSSLER, MJ
    DEVANE, J
    JOHNSON, KP
    NEUROLOGY, 1994, 44 (06) : 1054 - 1059
  • [2] Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine
    Rossini, PM
    Pasqualetti, P
    Pozzilli, C
    Grasso, MG
    Millefiorini, E
    Graceffa, A
    Carlesimo, GA
    Zibellini, G
    Caltagirone, C
    MULTIPLE SCLEROSIS, 2001, 7 (06): : 354 - 358
  • [3] THE EFFECT OF 4-AMINOPYRIDINE ON CLINICAL SIGNS IN MULTIPLE-SCLEROSIS - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, CROSS-OVER STUDY
    VANDIEMEN, HAM
    POLMAN, CH
    VANDONGEN, TMMM
    VANLOENEN, AC
    NAUTA, JJP
    TAPHOORN, MJB
    VANWALBEEK, HK
    KOETSIER, JC
    ANNALS OF NEUROLOGY, 1992, 32 (02) : 123 - 130
  • [4] Efficacy of 4-aminopyridine in downbeat nystagmus: A randomized, double-blind, placebo-controlled trial with crossover
    Danchaivijitr, C
    Kalla, R
    Brandt, T
    Kennard, C
    Bronstein, AM
    Strupp, M
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S48 - S49
  • [5] Effects of 4-aminopyridine on attention and executive functions of patients with multiple sclerosis: Randomized, double-blind, placebo-controlled clinical trial. Preliminary report
    Arreola-Mora, C.
    Silva-Pereyra, J.
    Fernandez, T.
    Paredes-Cruz, M.
    Bertado-Cortes, B.
    Grijalva, I
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 28 : 117 - 124
  • [6] A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF INFLUENZA IMMUNIZATION IN MULTIPLE-SCLEROSIS
    MILLER, AE
    MORGANTE, LA
    BUCHWALD, LY
    NUTILE, SM
    COYLE, PK
    KRUPP, LB
    DOSCHER, CA
    LUBLIN, FD
    KNOBLER, RL
    TRANTAS, F
    KELLEY, L
    SMITH, CR
    LAROCCA, N
    LOPEZ, S
    NEUROLOGY, 1995, 45 (04) : A436 - A436
  • [7] OUTCOME MEASURES IN RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND MULTIPLE-SCLEROSIS CLINICAL-TRIAL
    NOSEWORTHY, JH
    OBRIEN, PC
    NAESSENS, JM
    NEUROLOGY, 1994, 44 (04) : A392 - A392
  • [8] Efficacy and safety of 4-aminopyridine in patients with long-term spinal cord injury:: A randomized, double-blind, placebo-controlled trial
    Grijalva, I
    Guízar-Sahagún, G
    Castañeda-Hernández, G
    Mino, D
    Maldonado-Julián, H
    Vidal-Cantú, G
    Ibarra, A
    Serra, O
    Salgado-Ceballos, H
    Arenas-Hernández, R
    PHARMACOTHERAPY, 2003, 23 (07): : 823 - 834
  • [9] HYPERBARIC-OXYGEN IN MULTIPLE-SCLEROSIS - A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY
    CONFAVREUX, C
    MATHIEU, C
    CHACORNAC, R
    AIMARD, G
    DEVIC, M
    PRESSE MEDICALE, 1986, 15 (28): : 1319 - 1322
  • [10] A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis
    Vollmer, Timothy L.
    Robinson, Michael J.
    Risser, Richard C.
    Malcolm, Sandra K.
    PAIN PRACTICE, 2014, 14 (08) : 732 - 744
12345